{"id":"NCT02896127","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis","officialTitle":"Randomized, Double-blind, Placebo-controlled, Phase III Multicenter Study of Subcutaneous Secukinumab to Compare Efficacy at 16 Weeks With Placebo and Assess Safety and Tolerability up to 52 Weeks in Subjects With Active Ankylosing Spondylitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-10-18","primaryCompletion":"2018-05-14","completion":"2019-03-19","firstPosted":"2016-09-12","resultsPosted":"2020-12-30","lastUpdate":"2020-12-30"},"enrollment":458,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ankylosing Spondyloarthritis"],"interventions":[{"type":"DRUG","name":"Secukinumab","otherNames":["AIN457"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Secukinumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this trial is to demonstrate the clinical efficacy at week 16; and to demonstrate safety and tolerability of secukinumab compared to placebo in patients with ankylosing spondylitis at week 16 and long term safety up to Week 52.","primaryOutcome":{"measure":"The Proportion of Participants Who Achieve an ASAS 20 Response (Assessment of SpondyloArthritis International Society Criteria)","timeFrame":"Week 16","effectByArm":[{"arm":"Secukinumab","deltaMin":178,"sd":null},{"arm":"Placebo","deltaMin":56,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":1},"locations":{"siteCount":44,"countries":["China","Czechia","South Korea","United Kingdom"]},"refs":{"pmids":["35305260","34618347","32925287"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":33,"n":453},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Diarrhoea","Hepatic function abnormal","Alanine aminotransferase increased"]}}